China Taiping Insurance Holdings Co (0966) AI Stock Analysis

• Market Cap: HK$75.47B
• Dividend Yield: 1.81%
• Average Volume (3M): 10.79M
• Price to Earnings (P/E): 9.2
• Beta (1Y): 1.37
• Revenue Growth: 23.64%
• EPS Growth: 36.32%
• Country: HK
• Employees: 62,266
• Sector: Financial
• Sector Strength: 70
• Industry: Insurance - Life
• EPS (TTM): 1.74
• Shares Outstanding: 3,594,018,600
• 10 Day Avg. Volume: 11,963,404
• 30 Day Avg. Volume: 10,794,639
• PEG Ratio: 0.13
• Price to Book (P/B): 0.48
• Price to Sales (P/S): 0.35
• P/FCF Ratio: 0.36
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: HK$19.03
• Price Target Upside: -8.69% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 71 Outperform
• Price Target: HK$23.00 ▲(10.36% Upside)

China Taiping Insurance Holdings Co's strong financial performance and attractive valuation are the most significant factors contributing to its overall score. The technical analysis indicates moderate momentum, supporting a positive outlook. The absence of earnings call data and corporate events does not impact the score.

Positive Factors

Sustained Revenue Growth

Consistent premium and revenue growth reflects expanding underwriting scale and distribution effectiveness. Over the next 2–6 months this durable top-line momentum supports reserve funding, reinvestment in distribution, and better pricing leverage across life and P&C segments, strengthening long-term earnings capacity.

Improved Leverage and Balance Sheet

Material reduction in leverage increases financial flexibility and lowers solvency strain, enabling larger underwriting capacity and reduced refinancing risk. A stronger balance sheet supports regulatory capital resilience and strategic investments, durable advantages for multi-quarter stability and growth.

Strong Cash Generation

Robust operating cash flow and healthy free cash flow indicate efficient cash conversion from premiums and investments. This sustains liquidity for claims, reserve builds, and asset management, enabling consistent capital allocation to operations and long-term obligations over the medium term.

Negative Factors

Very Low Equity Ratio

A low equity proportion reduces the capital buffer against underwriting losses or market shocks, increasing the risk of regulatory capital pressure. Over months this structural capital thinness may necessitate capital raises or constrained growth if adverse claim or market scenarios materialize.

Unusual Reported EBIT Margin

Anomalous EBIT margin suggests one-off items, accounting irregularities, or reporting inconsistencies that obscure true operating profitability. Without clarity, margin sustainability and core underwriting economics remain uncertain, complicating medium-term earnings projections and capital planning.

Exposure to Investment Return Volatility

Heavy reliance on investment income makes underwriting profits sensitive to market cycles and interest rates. Structural volatility in asset returns can erode net income and capital via mark-to-market or yield shifts, requiring robust ALM and capital buffers to maintain solvency over the next several quarters.

China Taiping Insurance Holdings Co Business Overview & Revenue Model

Company Description

China Taiping Insurance Holdings Company Limited, an investment holding company, underwrites various insurance and reinsurance products in the People's Republic of China and internationally. The company operates through three business segments: Life Insurance, Property and Casualty Insurance, and Reinsurance. The Life Insurance segment provides life insurance products, such as individual and group life insurance, health insurance, and accident insurance products and annuities. The Property and Casualty Insurance segment offers compulsory motor insurance, liability insurance, credit insurance, guarantee insurance, and short-term accident and health insurance, as well as the related reinsurance products. The Reinsurance segment provides property damage, life, marine cargo and hull, and miscellaneous non-marine reinsurance products. The company also engages in the assets management, insurance intermediary, financial leasing, property investment, and securities dealing and broking, as well as in elderly care investment businesses; and manages investment funds. In addition, it provides corporate and personal retirement insurance products; and back-to-back financing arrangement, as well as insurance broking and agency services. The company was formerly known as China Insurance International Holdings Company Limited and changed its name to China Taiping Insurance Holdings Company Limited in August 2009. The company was incorporated in 2000 and is headquartered in North Point, Hong Kong. China Taiping Insurance Holdings Company Limited is a subsidiary of China Taiping Insurance Group (HK) Company Limited.

How the Company Makes Money

China Taiping Insurance generates revenue primarily through the sale of insurance premiums from its various insurance products, including life, health, and property insurance. The company collects premiums from policyholders, which form a significant portion of its income. Additionally, it earns investment income by investing the premiums received into various financial instruments, such as stocks, bonds, and real estate. The company also benefits from fee income generated from asset management services. Strategic partnerships with financial institutions and distribution channels enhance its reach, enabling China Taiping to expand its customer base and increase premium income.

China Taiping Insurance Holdings Co Financial Statement Overview

Summary

China Taiping Insurance Holdings Co demonstrates strong financial performance with significant revenue and profit growth, improved leverage, and effective cash flow management. The income statement reflects a positive growth trajectory, though the unusual EBIT margin requires further investigation. The balance sheet is stable, with room for improving the equity base.

Income Statement

The company shows strong revenue growth with a significant increase from 112.36 billion to 121 billion over the last year. Net profit margin improved from 4.78% to 6.97%, indicating better cost management. However, the EBIT margin fell from 17.72% to 100%, which requires further investigation as it seems unusual. Overall, the income statement reflects a positive growth trajectory with increasing profitability.

Balance Sheet

The balance sheet displays a stable debt-to-equity ratio, which decreased from 1.29 to 0.27, signifying improved leverage and financial health. The equity ratio stands at 5.02%, reflecting a low equity proportion, which is typical for insurance companies. Return on equity increased from 6.8% to 9.68%, indicating enhanced efficiency in generating profits from shareholders' equity. The balance sheet shows stability with some room for improving equity base.

Cash Flow

Operating cash flow remains strong and grew significantly from 134.6 billion to 125.95 billion. Free cash flow also shows a healthy growth rate, indicating robust cash generation capabilities. The operating cash flow to net income ratio is commendable, suggesting efficient cash conversion from earnings. The cash flow statement highlights strong liquidity and cash management practices.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	113.21B	121.00B	106.12B	158.81B	318.98B	277.07B
Gross Profit	113.21B	121.00B	123.32B	104.86B	316.11B	271.14B
EBITDA	18.59B	26.91B	19.85B	12.65B	16.45B	17.50B
Net Income	9.17B	8.43B	5.37B	4.30B	7.51B	6.55B
Balance Sheet
Total Assets	1.87T	1.73T	1.51T	1.41T	1.38T	1.17T
Cash, Cash Equivalents and Short-Term Investments	0.00	44.39B	42.55B	308.46B	293.80B	266.36B
Total Debt	33.28B	82.12B	101.43B	117.05B	95.17B	61.27B
Total Liabilities	1.74T	1.61T	1.38T	1.31T	1.27T	1.05T
Stockholders Equity	90.23B	87.07B	78.99B	75.51B	88.07B	90.65B
Cash Flow
Free Cash Flow	97.21B	116.24B	127.67B	88.72B	94.48B	110.33B
Operating Cash Flow	106.92B	125.95B	134.60B	95.02B	98.63B	114.20B
Investing Cash Flow	-158.04B	-95.63B	-130.95B	-80.30B	-99.62B	-110.85B
Financing Cash Flow	9.76B	-27.91B	19.79B	-9.76B	9.06B	-945.65M

China Taiping Insurance Holdings Co Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 20.84
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0966, the sentiment is Positive. The current price of 20.84 is above the 20-day moving average (MA) of 19.93, above the 50-day MA of 19.04, and above the 200-day MA of 15.69, indicating a bullish trend. The MACD of 0.73 indicates Negative momentum. The RSI at 59.72 is Neutral, neither overbought nor oversold. The STOCH value of 80.33 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0966.

China Taiping Insurance Holdings Co Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1336	83 Outperform	HK$256.41B	5.91	34.37%	5.24%	49.90%	203.77%
2628	83 Outperform	HK$1.40T	7.80	28.10%	3.42%	17.69%	126.41%
2601	79 Outperform	HK$454.49B	6.60	18.41%	3.28%	15.08%	23.13%
2318	78 Outperform	$1.31T	8.16	14.53%	4.25%	10.20%	19.74%
1299	72 Outperform	HK$887.32B	19.39	15.16%	2.16%	5.65%	30.47%
0966	71 Outperform	HK$75.47B	9.24	10.74%	1.81%	23.64%	36.32%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%

China Taiping Insurance Holdings Co Corporate Events

China Taiping Announces Board Changes with New Director Appointment

China Taiping Insurance Holdings Co announced changes in its board of directors, with the resignation of non-executive directors Mr. Guo Zhaoxu and Ms. Zhang Cui due to retirement. Mr. Feng Zhanwu has been appointed as a new non-executive director and member of the risk management committee. The company expressed gratitude to the outgoing directors for their contributions and welcomed Mr. Feng to the board. This change is part of the company’s ongoing governance and leadership strategy, potentially impacting its strategic direction and stakeholder relations.

The most recent analyst rating on (HK:0966) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.

China Taiping Announces Board Composition and Committee Roles

China Taiping Insurance Holdings Co has announced the composition of its board of directors and their roles within various board committees. This announcement highlights the leadership structure and governance framework of the company, which is crucial for stakeholders to understand the decision-making processes and strategic direction of the company.

The most recent analyst rating on (HK:0966) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.

China Taiping Divests Minority Stakes in Strategic Transaction

China Taiping Insurance Holdings Co, through its non-wholly owned subsidiary TPL, has entered into agreements to transfer its minority equity interests in four subject companies, including CRCCI and CRCC Kunlun, to CRCC for a total cash consideration of RMB6.50 billion. This transaction marks a strategic move for TPL, as it divests its stakes in these companies, potentially impacting its investment portfolio and financial strategy. The agreements ensure that all profits and losses incurred by the subject companies between the signing and closing dates will be managed by CRCC, indicating a clear transfer of operational responsibilities.

The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.

China Taiping Reports Strong Q3 2025 Financial Performance

China Taiping Insurance Holdings Co has announced the unaudited financial figures and solvency statement of its subsidiaries for the third quarter of 2025. The announcement highlights the financial performance of its subsidiaries, including Taiping Life Insurance, Taiping General Insurance, and Taiping Reinsurance, which are regulated by the National Financial Regulatory Administration. The financial report reveals a net profit of RMB 1,813,042,000 and significant cash flows from operating activities, indicating strong operational performance. The disclosure is part of regulatory requirements for insurance companies with issued capital supplementary bonds, providing stakeholders with insights into the company’s financial health and compliance.

The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.

China Taiping Reports Strong Solvency Position in Q3 2025

China Taiping Insurance Holdings Co announced the release of its subsidiaries’ solvency report for the third quarter of 2025. The report highlights the financial health and regulatory compliance of its subsidiaries under the China Risk Oriented Solvency System Phase II. The figures, based on unaudited preliminary data, indicate a strong solvency position, with a comprehensive solvency ratio of 248% at the end of the quarter, reflecting the company’s robust capital management and financial stability.

The most recent analyst rating on (HK:0966) stock is a Buy with a HK$18.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.